NCT05386732 is a clinical trial of Micro needling in Acne Scarring, sponsored by Dermapenworld.

Who is sponsoring NCT05386732?

NCT05386732 is sponsored by Dermapenworld.

What drugs are being tested in NCT05386732?

Interventions in NCT05386732: Micro needling.

What condition does NCT05386732 study?

NCT05386732 studies Acne Scarring.

Is NCT05386732 still recruiting?

NCT05386732 is currently completed. Last updated 27 May 2022.

Last reviewed 2022-05-27 · How we verify

NCT05386732

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Efficacy of the 4MD Micro Needling Device in the Treatment of Acne Scars

Completed Last updated 27 May 2022

What this trial tests

trial testing Micro needling in Acne Scarring in 22 participants. Completed in 9 October 2020.

Timeline

19 June 2020

Primary endpoint
9 October 2020

9 October 2020

Quick facts

Lead sponsor	Dermapenworld
Status	Completed
Study type	OBSERVATIONAL
Enrollment	22
Start date	19 June 2020
Primary completion	9 October 2020
Estimated completion	9 October 2020
Sites	1 location across Spain

Drugs / interventions tested

Micro needling

Conditions studied

Acne Scarring — all drugs for Acne Scarring →

Sponsor

Dermapenworld

Who can join

Adults 18 to 65, any sex, with Acne Scarring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this post market clinical follow-up study is to assess the safety and effectiveness of the 4MD microneedling device in reducing scarring of atrophic acne scars. The Primary endpoint was to show a reduction in acne scarring in accordance with the Acne Scar Assessment Scale as used by Skinpen (Bellus Medical (DEN160029)). Goodman and Baron and Jacob acne scar assessment and classification will also be utilized Safety endpoint: incidence of adverse events and side effects

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Micro needling

Trials testing the same drug.

NCT07280637 — Regenarative Treatment of Periocular Wrinkles With PDRN · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05386732 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dermapenworld
Last refreshed: 27 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05386732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing